Belly lining cancer patterns to guide colorectal cancer treatment
Part of Cancer, Digestive system clinical trials.
This study looks at the way colorectal cancer appears when it spreads to the lining of the belly (peritoneum). It aims to see if certain patterns in the tissue can help doctors decide on the best treatment, such as whether to recommend surgery with heated chemotherapy. Taking part does not change your treatment—it just allows researchers to study your tissue samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with colorectal adenocarcinoma (a type of bowel cancer).
- The cancer has spread (or may have spread) to the lining of your belly, known as the peritoneum.
- You are scheduled for, or have had, a laparoscopy (a small camera look inside your belly) or surgery to remove the cancer, sometimes with heated chemotherapy (HIPEC).
- You have a tissue sample from the belly lining that can be studied.
- You agree to take part and give written permission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people whose cancer has spread to the lining of the abdomen (the “belly lining”), including cancers from the digestive tract or ovaries. You may be asked to join because the study aims to learn how to better match care to different patterns of this belly lining cancer spread.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This study looks at colorectal cancer that has spread to the peritoneum (the lining around the belly) using existing tumor tissue samples. It may help researchers better understand the cancer’s biology and improve future treatments.
This study looks at how certain blood markers (nucleosome and CTCF) clear from the body in people with colorectal cancer that has spread to the lining of the belly. It also includes people with other conditions to compare. The goal is to learn more about these markers to help guide treatment.
This study looks at how cancers that spread along the belly lining (“peritoneal surface malignancies”) behave and how different treatment strategies may work. It may help improve how doctors select and test treatments for people who are candidates for CRS-HIPEC, a specific cancer surgery approach.
This study looks at samples of blood and tissue from people with advanced stomach cancer that has spread to the belly lining. The goal is to find markers that predict how well a treatment combining HIPEC (heated chemotherapy in the belly) with immunotherapy (drugs that help your immune system fight cancer) works.
Hear when a new Peritoneal (Metastatic) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.